Phase 1 Study of the Safety, Toxicity, Pharmacokinetics, Pharmacodynamics and Luminal Distribution of Single-dose DuoGel Through Rectal Administration
Phase of Trial: Phase I
Latest Information Update: 20 Dec 2017
At a glance
- Drugs IQP 0528 (Primary)
- Indications HIV infections
- Focus Adverse reactions; Pharmacokinetics
- 13 Dec 2017 Status changed from not yet recruiting to recruiting.
- 15 Aug 2017 Planned initiation date changed from 15 May 2017 to 1 Oct 2017.
- 21 Mar 2017 New trial record